Oncogene - Table of Contents alert Volume 36 Issue 13

If you are unable to see the message below, click here to view.

Advertisement The Return of the ChIP Kit With Diagenode’s ChIP Kit Customizer, buy only the kit-quality reagents that you want. Buy only what you need!  Select from individual components or full kits Validated, ChIP-grade reagents including buffers, beads, controls, antibodies, and more! Learn more. TABLE OF CONTENTS Volume 36, Issue 13 (March 2017) In this issue Review Original Articles Also new AOP Advertisement npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota. Explore the benefits of submitting your manuscript. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation. Now open for submissions >> Review Top Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development OPEN C T Tsai and C W E So Oncogene 2017 36: 1753-1759; advance online publication, September 5, 2016; 10.1038/onc.2016.315 Abstract | Full Text Original Articles Top MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation D-L Qi and D Cobrinik Oncogene 2017 36: 1760-1769; advance online publication, October 17, 2016; 10.1038/onc.2016.350 Abstract | Full Text Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells K E Richards, A E Zeleniak, M L Fishel, J Wu, L E Littlepage and R Hill Oncogene 2017 36: 1770-1778; advance online publication, September 26, 2016; 10.1038/onc.2016.353 Abstract | Full Text FERMT1 mediates epithelial–mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity C-C Liu, D-L Cai, F Sun, Z-H Wu, B Yue, S-L Zhao, X-S Wu, M Zhang, X-W Zhu, Z-H Peng and D-W Yan Oncogene 2017 36: 1779-1792; advance online publication, September 19, 2016; 10.1038/onc.2016.339 Abstract | Full Text Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium OPEN C S Daly, P Shaw, L D Ordonez, G T Williams, J Quist, A Grigoriadis, J H Van Es, H Clevers, A R Clarke and K R Reed Oncogene 2017 36: 1793-1803; advance online publication, October 3, 2016; 10.1038/onc.2016.342 Abstract | Full Text HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer N Stojanovic, Z Hassan, M Wirth, P Wenzel, M Beyer, C Schäfer, P Brand, A Kroemer, R H Stauber, R M Schmid, A Arlt, A Sellmer, S Mahboobi, R Rad, M Reichert, D Saur, O H Krämer and G Schneider Oncogene 2017 36: 1804-1815; advance online publication, October 10, 2016; 10.1038/onc.2016.344 Abstract | Full Text The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion OPEN S R Frank, C P Köllmann, J F van Lidth de Jeude, J R Thiagarajah, L H Engelholm, M Frödin and S H Hansen Oncogene 2017 36: 1816-1828; advance online publication, September 26, 2016; 10.1038/onc.2016.345 Abstract | Full Text Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.− upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells M-U-D Lone, K S Baghel, R K Kanchan, R Shrivastava, S A Malik, B N Tewari, C Tripathi, M P S Negi, V K Garg, M Sharma, M L B Bhatt and S Bhadauria Oncogene 2017 36: 1829-1839; advance online publication, October 10, 2016; 10.1038/onc.2016.346 Abstract | Full Text Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora OPEN W Bruinsma, M Aprelia, I García-Santisteban, J Kool, Y J Xu and R H Medema Oncogene 2017 36: 1840-1848; advance online publication, October 10, 2016; 10.1038/onc.2016.347 Abstract | Full Text Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells OPEN F Faião-Flores, D K Alves-Fernandes, P C Pennacchi, S Sandri, A L S A Vicente, C Scapulatempo-Neto, V L Vazquez, R M Reis, J Chauhan, C R Goding, K S Smalley and S S Maria-Engler Oncogene 2017 36: 1849-1861; advance online publication, October 17, 2016; 10.1038/onc.2016.348 Abstract | Full Text Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer R Mimoto, Y Imawari, S Hirooka, H Takeyama and K Yoshida Oncogene 2017 36: 1862-1872; advance online publication, October 10, 2016; 10.1038/onc.2016.349 Abstract | Full Text Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway OPEN Q Zhou, X Wang, Z Yu, X Wu, X Chen, J Li, Z Zhu, B Liu and L Su Oncogene 2017 36: 1873-1886; advance online publication, October 3, 2016; 10.1038/onc.2016.352 Abstract | Full Text The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3 Z Li, B Bridges, J Olson and S A Weinman Oncogene 2017 36: 1887-1898; advance online publication, September 26, 2016; 10.1038/onc.2016.359 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.